• A Settlement totaling $275,000,000 has been reached in a class action lawsuit against Sandoz Inc. and Fougera Pharmaceuticals Inc. (“Sandoz”) and other generic manufacturers (the “Non-Settling Defendants”) about how much they paid for certain prescription generic drugs.

• You may be able to recover money from the Settlement if you are a consumer or third-party payor who is in any of the 50 United States (except Indiana and Ohio), as well as the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, and indirectly purchased, paid, and/or provided reimbursement for some or all of the purchase price for any Named Generic Drugs, other than for resale, from May 1, 2009 to December 31, 2019.

• The deadlines may be amended by Court Order. Please check this website regularly for updates.

The information contained on this website is only a summary. You may download a copy of the full Notice by clicking here. Since this website is just a summary, you should review the Notice for additional details.

Your legal rights might be affected by a proposed $275,000,000 Settlement in a class action lawsuit (In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724) pending in the United States District Court for the Eastern District of Pennsylvania. The lawsuit has been brought by End-Payer Plaintiffs ("EPPs") and claims that Sandoz Inc. and Fougera Pharmaceuticals Inc. (“Sandoz”) and other generic manufacturers (the “Non-Settling Defendants”) violated federal and state antitrust laws, consumer protection statutes, and common law, causing End-Payers – including consumers and Third-Party Payers (“TPPs”) (e.g., entities such as insurers or employers with self-funded prescription drug plans) – to pay more than they should have for certain prescription generic drugs (“Named Generic Drugs”). Sandoz denies that it is liable to End-Payers. The Court has not decided who is right. The lawsuit remains ongoing against the Non-Settling Defendants. For additional details, instructions and answers to frequently asked questions, please read the Notice.

The Court will hold a Fairness Hearing on July 23, 2025 at 11:00 a.m. to decide whether to approve the Settlement, the Plan of Allocation, and any request for attorneys’ fees, expenses, or service awards. Money will be distributed if and after the Court approves the Settlement. The amount and the timing of payment will be based on a Plan of Allocation that must be approved by the Court. EPPs’ proposed Plan of Allocation is posted on the Court Documents page. The claims process will open at a later date. To receive settlement-related updates, including when claim forms are available, you should register on the Registration page or call the toll-free number below.

Toll-free number: 1-877-316-0171

Who is Included?

You may be an EPP Sandoz Settlement Class Member if:

You are in any of the 50 United States (except Indiana and Ohio), as well as the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, and indirectly purchased, paid, and/or provided reimbursement for some or all of the purchase price for any Named Generic Drugs, other than for resale, from May 1, 2009 to December 31, 2019.

You are NOT a member of the EPP Sandoz Settlement Class if you are among any of the following:

1. Defendants, their officers, directors, management, employees, subsidiaries and affiliates;
2. all federal governmental entities;
3. all state governmental entities (except for cities, towns, municipalities, counties and other local governmental entities with self-funded prescription drug plans, all of which are included in the class);
4. all governmental Medicaid agencies, private Medicaid managed care organizations, and consumers who were covered by Medicaid for their purchases of Named Generic Drugs;
5. Judges assigned to this case and any members of their immediate families;
6. persons or entities who only purchased Defendants’ Named Generic Drugs for purposes of resale or directly from Defendants;
7. fully insured employers to the extent that they use fully-insured plans (i.e., employers that purchased insurance covering 100% of their reimbursement obligation to members); or
8. pharmacy benefit managers.

If you made purchases that meet the definition of the Settlement Class, but also made purchases that fall within one or more of the exclusions above, you are included in the Settlement Class only with respect to those purchases that meet the definition of the Settlement Class.

More Information

This website contains a summary of the Settlement and relevant Court papers. If you have questions about the Settlement or want additional information, you should first review the information posted on this Settlement Website. If you still have questions, you may call the Notice Administrator at 1-877-316-0171 or contact the attorney or law firm identified on the Contact page of this website.